211 related articles for article (PubMed ID: 36064262)
1. mRNA-based therapies: Preclinical and clinical applications.
Qureischi M; Mohr J; Arellano-Viera E; Knudsen SE; Vohidov F; Garitano-Trojaola A
Int Rev Cell Mol Biol; 2022; 372():1-54. PubMed ID: 36064262
[TBL] [Abstract][Full Text] [Related]
2. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
Kang DD; Li H; Dong Y
Adv Drug Deliv Rev; 2023 Aug; 199():114961. PubMed ID: 37321375
[TBL] [Abstract][Full Text] [Related]
3. Synthetic modified messenger RNA for therapeutic applications.
Gao M; Zhang Q; Feng XH; Liu J
Acta Biomater; 2021 Sep; 131():1-15. PubMed ID: 34133982
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.
Gómez-Aguado I; Rodríguez-Castejón J; Vicente-Pascual M; Rodríguez-Gascón A; Solinís MÁ; Del Pozo-Rodríguez A
Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32093140
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.
Guan S; Rosenecker J
Gene Ther; 2017 Mar; 24(3):133-143. PubMed ID: 28094775
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules.
Zhang J; Liu Y; Li C; Xiao Q; Zhang D; Chen Y; Rosenecker J; Ding X; Guan S
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765153
[TBL] [Abstract][Full Text] [Related]
7. Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape.
Miliotou AN; Georgiou-Siafis SK; Ntenti C; Pappas IS; Papadopoulou LC
Curr Issues Mol Biol; 2023 Nov; 45(11):9181-9214. PubMed ID: 37998753
[TBL] [Abstract][Full Text] [Related]
8. mRNA vaccines: the most recent clinical applications of synthetic mRNA.
Kwon S; Kwon M; Im S; Lee K; Lee H
Arch Pharm Res; 2022 Apr; 45(4):245-262. PubMed ID: 35426547
[TBL] [Abstract][Full Text] [Related]
9. In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development.
Miliotou AN; Papadopoulou LC
Methods Mol Biol; 2020; 2086():87-117. PubMed ID: 31707670
[TBL] [Abstract][Full Text] [Related]
10. Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.
Steinle H; Behring A; Schlensak C; Wendel HP; Avci-Adali M
Stem Cells; 2017 Jan; 35(1):68-79. PubMed ID: 27250673
[TBL] [Abstract][Full Text] [Related]
11. Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing.
Youssef M; Hitti C; Puppin Chaves Fulber J; Kamen AA
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892179
[TBL] [Abstract][Full Text] [Related]
12. The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics.
Muslimov A; Tereshchenko V; Shevyrev D; Rogova A; Lepik K; Reshetnikov V; Ivanov R
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834268
[TBL] [Abstract][Full Text] [Related]
13. Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety.
Vlatkovic I
Biomedicines; 2021 May; 9(5):. PubMed ID: 34068715
[TBL] [Abstract][Full Text] [Related]
14. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z; Tian Y; Song J; An G; Yang P
Front Immunol; 2022; 13():887125. PubMed ID: 35720301
[TBL] [Abstract][Full Text] [Related]
15. mRNA: A promising platform for cancer immunotherapy.
Kong B; Kim Y; Kim EH; Suk JS; Yang Y
Adv Drug Deliv Rev; 2023 Aug; 199():114993. PubMed ID: 37414361
[TBL] [Abstract][Full Text] [Related]
16. Emerging mRNA technologies: delivery strategies and biomedical applications.
Xiao Y; Tang Z; Huang X; Chen W; Zhou J; Liu H; Liu C; Kong N; Tao W
Chem Soc Rev; 2022 May; 51(10):3828-3845. PubMed ID: 35437544
[TBL] [Abstract][Full Text] [Related]
17. mRNA-based therapeutics--developing a new class of drugs.
Sahin U; Karikó K; Türeci Ö
Nat Rev Drug Discov; 2014 Oct; 13(10):759-80. PubMed ID: 25233993
[TBL] [Abstract][Full Text] [Related]
18. Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity.
Warzak DA; Pike WA; Luttgeharm KD
SLAS Technol; 2023 Oct; 28(5):369-374. PubMed ID: 37833008
[TBL] [Abstract][Full Text] [Related]
19. mRNA-based therapeutics: looking beyond COVID-19 vaccines.
Parhiz H; Atochina-Vasserman EN; Weissman D
Lancet; 2024 Mar; 403(10432):1192-1204. PubMed ID: 38461842
[TBL] [Abstract][Full Text] [Related]
20. Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine.
Kwon H; Kim M; Seo Y; Moon YS; Lee HJ; Lee K; Lee H
Biomaterials; 2018 Feb; 156():172-193. PubMed ID: 29197748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
